The Local Lymph Node Assay: DA (LLNA: DA) is a non-radioactive modification to the LLNA method for identifying potential skin sensitizing test substances and measuring the proliferation of lymphocytes they induce in the auricular lymph nodes. The method, described in mouse (CBA/J strain), is based on measurement of the adenosine triphosphate (ATP) content by bioluminescence as an indicator of this proliferation. A minimum of four animals is used per dose group, with a minimum of three concentrations of the test substance, plus a concurrent negative control group and, if appropriate, a positive control group. The experimental schedule is during 8 days. The time from animal sacrifice to measurement of ATP should not exceed 30 min. The procedure from excision of lymph nodes to ATP measurement should be kept uniform for each animal and completed within 20 minutes. The luciferin/luciferase method is applied to measure the bioluminescence in Relative Luminescence Units (RLU). This study includes: measurements (weighing, RLU), and clinical daily observations. The results are expressed as the Stimulation Index (SI) obtained by calculation. The SI should be ¡Ý1.8 before further evaluation of the test material as a potential skin sensitizer is warranted.
Test No. 442A: Skin Sensitization
Local Lymph Node Assay: DA
Report
Share
Facebook
Twitter
LinkedIn
Abstract
In the same series
-
25 June 202536 Pages
-
25 June 202532 Pages
-
25 June 202582 Pages
-
Report
Assays addressing the Adverse Outcome Pathway key event on covalent binding to proteins
25 June 202563 Pages -
25 June 202527 Pages
Related publications
-
15 December 2025169 Pages
-
Report3 December 202594 Pages
-
30 June 2025193 Pages
-
Working paper30 June 2025250 Pages
-
30 June 2025329 Pages
-
Working paper30 June 2025270 Pages